Skip to content

EV / EBITDA at other companies

Humana logo
HumanaHUM
11.7×+1.2×
CVS Health logo
CVS HealthCVS
9.2×+2.7×
UnitedHealth Group logo
UnitedHealth GroupUNH
12.8×-1.3×
Astrana Health logo
Astrana HealthASTH
13.8×-0.8×
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
-2.9×
Alignment Healthcare logo
Alignment HealthcareALHC
48.5×

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+150%
Enterprise value$1.31B+130%
P/S1.4×+0.7×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Calculated from InnovAge Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s EV / EBITDA?
InnovAge Holdings, Inc. (INNV) reported EV / EBITDA of 127.8× in Q1 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.